Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib March 10, 2018 admin CEO Interview, Healthcare Comments Off on Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. Your privacy is our priority. Your email address will never be sold or shared with anyone else.